GlassScriptPhysician profile
Bruce L Fetterman
NPI 1699881052
$632.55
in general payments reported to CMS, 2019-2025
7 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.64 · 2022: $45.76 · 2023: $94.30 · 2024: $208 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $305.20 | 2024-2025 | |
| Glaxosmithkline, LLC. | $193.73 | 2023-2025 | Nucala |
| Merck Sharp & Dohme LLC | $33.54 | 2021-2022 | |
| Medtronic, INC. | $27.86 | 2022 | |
| Hologic Sales and Service, LLC | $24.54 | 2023 | Coolseal Generator |
| Regeneron Healthcare Solutions, INC. | $24.32 | 2024 | Dupixent |
| Baxter Healthcare | $23.36 | 2023 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Fetterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.